The COVID-19 pandemic forced investigators conducting clinical trials to use decentralized elements, such as telehealth, to ...

The US Food and Drug Administration has released draft guidance on protocol deviations, but experts say it could go further.

With the FDA quietly rolling back DEI initiatives under Trump’s latest executive order, experts warn that underrepresentation ...

In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...

A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...

In an effort to safeguard fair market competition and protect consumer interests, the State Council's anti-monopoly ...

National conference on pharmaceutical quality assurance and GMP guidelines with industry experts and government officials at AMTZ, Andhra Pradesh.

In this interview, we explore the key changes shaping the pharmaceutical industry, maintaining compliance across global ...

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA ...

Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...

The FDA ban comes on the cusp of potentially bigger changes in the food industry under the incoming ... continue to follow and comply with FDA’s guidance and safety standards.” ...